Population Pharmacokinetics of Fludarabine in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Fludarabine (Primary)
- Indications Haematological malignancies
- Focus Biomarker; Pharmacodynamics; Pharmacokinetics
- 07 Oct 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 07 Oct 2013 Planned number of patients changed from 45 to 75 as reported by ClinicalTrials.gov.
- 26 Sep 2011 Additional lead trial center identified as reported by ClinicalTrials.gov.